Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 50742-335

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 50742-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

Chemical structure of pramipexole dihydrochloride monohydrate showing the molecular arrangement including its amine, thiazole, and cyclohexane components with hydrochloride and water molecules.*

FDA Label Image

Image (Image 02)

A data table presenting the imprints on extended-release Pramipexole dihydrochloride tablets by Ingenus Pharmaceuticals, LLC for strengths 0.375 mg through 4.5 mg. The front imprint shows the tablet strength (e.g., '0.375', '0.75', '1.5'), while the back imprint displays codes from 'P11' to 'P17' corresponding with increasing strengths.*

FDA Label Image

0.375mg (Image 03)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.375 mg, oral tablet dosage form. The label indicates a 30-tablet bottle by Ingenus Pharmaceuticals, LLC, with dosing instructions as once daily and storage guidance. The label includes NDC 50742-331-30 and states the tablets must be swallowed whole. Manufactured for Ingenus Pharmaceuticals, LLC, Orlando, FL.*

FDA Label Image

0.75mg (Image 04)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.75 mg strength, oral dosage form, manufactured by Ingenus Pharmaceuticals, LLC. The label states the product is for once-daily use, contains 30 tablets, and includes storage and usage instructions. The NDC is 50742-332-30, and the label is marked Rx only.*

FDA Label Image

1.5mg (Image 05)

Pramipexole Dihydrochloride Extended-Release Tablets 1.5 mg by Ingenus Pharmaceuticals, LLC. Oral tablets in a 30 count package. Label highlights once daily dosage and original unit-of-use container packaging. Includes NDC 50742-333-30 and storage instructions.*

FDA Label Image

2.25mg (Image 06)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 2.25 mg, oral tablets by Ingenus Pharmaceuticals, LLC. The container holds 30 tablets with a once-daily dosage indication. The label includes dosage information, storage instructions, and manufacturer details, along with a barcode and lot/expiration area.*

FDA Label Image

3mg (Image 07)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 3 mg by Ingenus Pharmaceuticals, LLC. The label states the dosage form as extended-release tablets, with a strength of 3 mg, and instructions for once daily use. It includes NDC 50742-335-30, storage instructions, and manufacturer information in Orlando, FL. The package contains 30 tablets and features dosage and handling warnings, barcodes, and lot/expiration details.*

FDA Label Image

3.75mg (Image 08)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 3.75 mg strength, oral dosage form, manufactured by Ingenus Pharmaceuticals, LLC. The label states 'Once Daily' dosing and that the package contains 30 tablets. It includes storage instructions, dosage directions, lot and expiration dates, and a barcode with GTIN.*

FDA Label Image

4.5mg (Image 09)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 4.5 mg strength. The label indicates the product is manufactured for Ingenus Pharmaceuticals, LLC and contains 30 tablets. Directions state the medication is taken once daily, with storage instructions and dosage warnings included. A barcode and lot/expiration information section are also visible.*

FDA Label Image

Image (Image 10)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.